Wednesday, February 10, 2010, 7:57am EST - Canadian Markets open in 1 hour and 33 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Given Imaging Ltd. (GIVN)

On Feb 9: 15.13 USD   0.00 (0.00%)  
MORE ON GIVN
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Given Imaging Ltd. (NGM:GIVN) Delayed quote dataEdit
Last Trade: 15.13 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 15.13
Open: N/A
Bid: 14.89 x 300
Ask: 15.37 x 300
1y Target Est: 20.04
Day's Range: N/A - N/A
52wk Range: 6.76 - 18.37
Volume: 0
Avg Vol (3m): 166,056
Market Cap: 443.22M
P/E (ttm): 66.36
EPS (ttm): 0.23
Div & Yield: 0.54 (3.57%)
Given Imaging Ltd. (GIVN)
1d  5d  3m  6m  1y  2y  5y  max 
 Add GIVN to Portfolio   Download Data

HEADLINES
Given Imaging to Host Fourth Quarter 2009 Financial Results Conference Calls
Marketwire (Mon, Feb 1)
Given Imaging to Present at the 28th Annual J.P. Morgan Healthcare Conference
Marketwire (Wed, Jan 6)
ObamaCare Using PBMs As A Solution To High Health Care Costs: Which Stocks To Benefit?
Wall Street Transcript (Wed, Dec 16)
Given Imaging Enters Oversold Territory
Zacks.com (Tue, Dec 15)
The 200-Day Moving Average & 3 PowerRatings Stocks for Traders
TradingMarkets.com (Tue, Dec 15)
Three Studies Find PillCam(R) SB Enables Earlier Diagnosis and Treatment of GI Diseases Including Crohn's
Marketwire (Wed, Nov 25)
Given Imaging Announces RAPID(R) pH Software for Bravo(R) pH Monitoring System
Marketwire (Tue, Nov 24)
New Studies Show PillCam(R) SB to Be Clinically Valuable in Classifying and Managing Pediatric GI Symptoms
Marketwire (Tue, Nov 24)
Given Imaging Meeting to Discuss New Features of PillCamĀ® COLON 2 and Review Results from Israeli Feasibility Trial Call scheduled for 9:00 am ET today
CCBN (Mon, Nov 23)
Given Imaging Launches Next-Generation PillCam(R) COLON 2 at GASTRO 2009 Conference
Marketwire (Mon, Nov 23)
Israel Stocks: Israel stocks off; Africa Times-building deal seen
at MarketWatch (Thu, Nov 19)
More Headlines for GIVN...

ANALYST
EPS Est (next year) (Dec-09) : 0.43
EPS Est (in 2 years) (Dec-10) : 0.50
Avg Rec (current)*: 1.8
PEG Ratio: 1.47
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Given Imaging Ltd. develops, manufactures, and markets diagnostic products for the visualization and detection of disorders of the gastrointestinal tract.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices